ACE2 |
Angiotensin-converting enzyme 2 |
ARDS |
Acute Respiratory Distress Syndrome |
AT |
Antithrombin |
C-C Chemokine Receptor 2 |
CCR2 |
C-C Chemokine Receptor 5 |
CCR5 |
C-C Chemokine Receptor 7 |
CCR7 |
C-C Chemokine Ligand 2 |
CCL2/MCP-1 |
C-C Chemokine Ligand 4 |
CCL4/MIP-1β |
C-C Chemokine Ligand 5 |
CCL5/RANTES |
CD69 |
Cluster of Differentiation 69 |
COVID-19 |
Coronavirus Disease of 2019 |
DIC |
Disseminated Intravascular Coagulation |
E |
Envelope protein |
EMA |
European Medicines Agency |
FDA |
Food and Drug Administration |
FDA EUA |
FDA Emergency Use Authorization |
FITC |
Fluorescein Isothiocyanate |
HE |
Hemagglutinin-esterase protein |
IL-1 |
Interleukin-1 |
IL-10 |
Interleukin-10 |
IL-6 |
Interleukin-6 |
IRF |
Interferon Regulatory Factor |
KD |
Dissociation constant |
LBP |
LPS-binding protein |
LPS |
Lipopolysaccharide |
M |
Membrane protein |
MD-2 |
Myeloid differentiation factor 2 |
MODS |
Multiple Organ Dysfunction Syndrome |
N |
Nucleocapsid protein |
NIH |
US National Institutes of Health |
NF-κB |
Nuclear Factor Kappa-B |
PD-1 |
Programmed Death-1 |
S |
Spike protein |
SARS |
Severe Acute Respiratory Syndrome |
SARS-CoV-2 |
Coronavirus 2 cause of SARS |
TGF-β1 |
Transforming Growth Factor Beta 1 |
TLR4 |
Toll-like receptor 4 |
TNF-α |
Tumor Necrosis Factor Alpha |